Researchers at the Indian Institute of Science (IISc) report that a combination of antibiotics can reverse drug resistance in tuberculosis. All three outlets describe the work as a potential approach to tackling drug-resistant TB, focusing on the antibiotic regimen rather than on a broader policy or treatment rollout.
The coverage is largely aligned on the core claim: IISc-led research identifies an antibiotic combination that addresses resistance. The Times of India pieces present the finding using similar phrasing and emphasis, effectively reiterating the same theme about reversing drug resistance in TB. The Hindu frames the report around IISc researchers combining antibiotics to tackle drug-resistant TB, keeping the focus on the scientific method and purpose.
Across the articles, the main difference lies in wording and emphasis—whether the headline foregrounds “combination” or “reverse drug resistance”—but they converge on the same event: IISc researchers have produced results suggesting antibiotic combinations may restore TB drug sensitivity.